This issue brief reviews the evidence-base to assess the impact of HR 5376 on drug innovation and patient health. A large academic literature estimates the effect of future drug revenues on R&D spending and finds that on average that a 1 percent reduction in revenue leads to a 1.5 percent reduction in R&D activity. We find that HR 5376 will reduce revenues by 12.0 percent through 2039 and therefore that the evidence base predicts that R&D spending will fall about 18.5 percent, amounting to $663 billion. We find that this cut in R&D activity leads to 135 fewer new drugs. This drop in new drugs is predicted to generate a loss of 331.5 million life years in the US, 31 times as large as the 10.7 million life years lost from COVID-19 in the US to date. These estimated effects on the number of new drugs brought to market are 27 times larger than projected by CBO, which finds only 5 drugs will be lost through 2039, equaling a 0.63 percent reduction. Click here to read the full paper.
Issue Brief: The Impact of HR 5376 on Biopharmaceutical Innovation and Patient Health
Luxury Lounge HiOP
Top Holidaymaker Destinations That You Need To Experience
On Your Tour To Vietnam 베트남유흥
I visited multiple web sites however the audio feature for audio songs existing at
this website is really superb.
my blog post; lipozem coupon
I have read several excellent stuff here. Certainly value bookmarking for revisiting.
I wonder how much effort you place to create one of these great
informative website.
Also visit my website :: slot
I was recommended this blog via my cousin. I’m not positive whether this post is
written via him as no one else understand such specific about my difficulty.
You are wonderful! Thank you!
Stop by my website: escort service Unnao
A Buyer’s Guide To Your New Iphone 부산달리기
Very soon this web page will be famous among all blogging
and site-building people, due to it’s nice articles or reviews
My blog Private Proxies Cheap